MME and inflammatory bowel disease: In summary, our results suggest that the design and synthesis of novel enkephalinase inhibitors is a promising direction in the search for novel anti-IBD drugs and could become an alternative for patients for whom current treatments (NSAIDs, corticosteroids) do not provide sufficient relief.